Promising Opportunities Present in the Patient Monitoring Industry
- How will the adoption of digital platforms propel growth?
- What best practices should vendors integrate for growth in this landscape?
- How do emerging megatrends like wearables and connected patient monitoring devices, create opportunities?
Hospital Workflow Digital Platforms and Solutions: What Are the Top Opportunities?
- Identify key growth strategies for clinical workflows amidst changing dynamics.
- Analyze the impact of virtual care and digital documentation technology.
- Evaluate megatrends influencing the adoption of hospital workflow digital platform solutions across the healthcare space.
Key Megatrends Transforming the Patient Engagement Platforms and Solutions
- How are digital health solutions fueling the industry’s growth?
- How are disruptive technologies reshaping patient engagement strategies globally?
- What best practices can stakeholders adopt to leverage growth in this evolving landscape?
Enterprise Managed Cloud Services
What best practices are emerging for cybersecurity in healthcare as cloud adoption increases?
Opportunities in Sports Medicine
Examine how you can leverage megatrends in injury prevention and recovery to achieve growth
Artificial Intelligence-Enabled Clinical Trials
Leverage best practices that help reduce cost and increase efficiency for ideal growth
Hospital-at-Home (HaH) Platforms
Foster technological solutions supporting acute care management through HaH.
Emerging Respiratory Care Companies
How can your company leverage new opportunities for accelerated growth?
Diabetes and Obesity Therapeutics
What are the most promising growth opportunities for your business in this landscape?
Growth in the Heart Valves Industry
Which growth strategies can help you gain a competitive edge over top companies?
Oral Solid Dosage Formulations
Leverage personalized medicine and drug delivery technologies to enhance growth
Why Are Cardiometabolic Diseases a Growing Concern? Is Your Company Equipped to Address this Challenge?
Cardiometabolic diseases, including cardiovascular conditions, type 2 diabetes, and obesity, are increasing globally, straining healthcare systems and escalating costs.
Traditional one-size-fits-all drug therapies lack patient-centricity and fail to address individual variability, highlighting the need for affordable, accessible treatments.
Frost Analytics: Discerning Biotech Bankruptcies in 2023
Biotech bankruptcies reached a record high in 2023 with over 20 companies announcing insolvency. Financial struggles in a post-COVID-19 economy and rising inflation have adversely impacted the global biotech industry.
The financial troubles in the biotech space are likely to prevail in 2024 across both large and small biotech companies. Large pharma companies need to innovate quickly to off-set emerging losses due to patent expiration.
The biotech start-up struggle is focused on securing larger financing and getting better returns on minimal investments.
Top 10 Strategic Imperatives: Navigating the AI-Driven Revolution in Precision Health
Amidst the complexities of the healthcare landscape, Precision Health is emerging as a transformative solution, offering personalized care and precise interventions.
Artificial intelligence (AI) is driving this revolution by unlocking the potential of Precision Health through vast data integration, propelling drug discovery, development, and elevating patient care.
In the coming years, AI will enable novel drug targets and personalized treatments, leading to improved health outcomes.
Etiometry Awarded Frost & Sullivan’s 2024 North American Enabling Technology Leadership Award for Leading Innovation in Clinical Decision Support Systems
Frost & Sullivan analyzed the clinical decision support for critical care industry and, based on its findings, recognizes Etiometry with the 2024 North American Enabling Technology Leadership Award.
Etiometry is a leading provider of clinical decision-support software for the intensive care unit (ICU) environment, revolutionizing the industry with its unique software and application.
Ansell Recognized with the Frost & Sullivan 2024 Global Company of the Year Award for Revolutionizing Workplace Safety and Promoting Sustainability
Frost & Sullivan analyzed and conducted a review of the global healthcare supplies industry and based on its findings, recognizes Ansell with the 2024 Global Company of the Year Award.
Ansell is a global leader in protection solutions, specializing in safety products, such as gloves and personal protective equipment (PPE), to protect workers in various verticals industries, including healthcare, laboratory, life sciences, industrial and automotive.
Clinion Applauded by Frost & Sullivan for Enabling Interoperability and Continuity in Clinical Trials Management with its eClinical Solutions
Frost & Sullivan analyzed the integrated clinical trial optimization industry and, based on its findings, recognizes Clinion with the 2024 North American Technology Innovation Leadership Award.
The company is an innovator in the clinical trial and data management space. It simplifies clinical trial management by sharing consistent trial data, leading to accelerated clinical development, reduced trial costs, increased compliance, and faster industry entry.
Healthcare IT
Growth Opportunities in Hospital-at-Home Platforms & Services in the United States and Europe: Will Regulatory and Reimbursement Policies Define the Success of Hospital-at-Home Platforms?
Aug 28th, 2024 11:00 AM EDT
On-demand Webinars
Discover a wide range of growth opportunities that can help you thrive amidst the transformation of precision health, chronic care, healthcare information technology, and women's health.
On-demand
Growth Processes
Explore the major growth opportunities impacting manufacturing, mergers and acquisitions, technology, strategy, vision, innovation, leadership, and more.
August 2024
